INNOCOLL HOLDINGS, INC.

Profile

Company Names

INNOCOLL HOLDINGS, INC.

Addresses

42662 KITCHEN PRIM CT., ASHBURN, VA 20148

Phone Numbers

703-980-4182

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$31,314,927.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2013-01-22 
$1,464,894.00 
$1,464,894.00 
$0.00 
Equity, Debt 
9
2012-11-01 
$2,000,002.00 
$2,000,002.00 
$0.00 
Equity, Debt 
8
2012-06-26 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity, Debt 
7
2012-01-24 
$1,100,031.00 
$1,100,031.00 
$0.00 
Equity, Debt 
6
2011-06-28 
$3,250,000.00 
$3,250,000.00 
$0.00 
Equity, Debt 
5
2011-03-22 
$3,250,000.00 
$3,250,000.00 
$0.00 
Equity, Debt 
4
2010-08-13 
$5,250,000.00 
$5,250,000.00 
$0.00 
Equity, Debt 
3
2010-05-13 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity, Debt 
2
2009-12-21 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
1
2009-04-22 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
COURTNEY 
 
CARSON 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  HEIN PARK INVESTORS LP
JAMES 
 
CULVERWELL 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  QUOIN PHARMACEUTICALS, LTD.   |  TC BIOPHARM (HOLDINGS) PLC
GORDON 
 
DUNN 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  QUOIN PHARMACEUTICALS, LTD.
KENNETH 
E. 
HIGGINS 
DIRECTOR
INNOCOLL HOLDINGS, INC.
DENNIS 
 
LANGER 
DIRECTOR
DICERNA PHARMACEUTICALS INC   |  LIGHT SCIENCES ONCOLOGY INC   |  INNOCOLL HOLDINGS, INC.   |  SANCILIO + COMPANY, INC.   |  ALZHEON, INC.   |  SANCILIO PHARMACEUTICALS COMPANY, INC.   |  MYRIAD GENETICS INC   |  QUOIN PHARMACEUTICALS, INC.   |  NEXEOS DIAGNOSTICS, INC.   |  BROOKLYN IMMUNOTHERAPEUTICS, INC.   |  QUOIN PHARMACEUTICALS, LTD.   |  AVICENNA BIOSCIENCES, INC.   |  EMPIRICO INC.
MICHAEL 
 
MYERS 
EXECUTIVE OFFICER, DIRECTOR
INNOCOLL HOLDINGS, INC.   |  PETITIONERS INC   |  TEN OAKS PARTNERS, LLC   |  CALIBRUS, INC.   |  HANCOCK REGIONAL SURGERY CENTER, LLC   |  QUOIN PHARMACEUTICALS, LTD.
WILLIAM 
 
O-DONNELL 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  ROCHDALE ALTERNATIVE TOTAL RETURN FUND LLC   |  ROCHDALE INTERNATIONAL TRADE FIXED INCOME FUND   |  ROCHDALE ROYALTY RIGHTS FUND LLC   |  CITY NATIONAL ROCHDALE HIGH YIELD ALTERNATIVE STRATEGIES FUND LLC   |  CITY NATIONAL ROCHDALE HIGH YIELD ALTERNATIVE STRATEGIES FUND TEI LLC   |  CITY NATIONAL ROCHDALE STRUCTURED CLAIMS FIXED INCOME FUND LLC   |  CITY NATIONAL ROCHDALE ALTERNATIVE TOTAL RETURN FUND LLC   |  CITY NATIONAL ROCHDALE INTERNATIONAL TRADE FIXED INCOME FUND   |  BLADE NETWORK, LLC   |  ROCHDALE GML TRADE FINANCE INCOME FUND LTD   |  ROCHDALE OFFSHORE GLOBAL DIVERSIFICATION FUND, LTD.   |  ROCHDALE OFFSHORE GLOBAL OPPORTUNITIES FUND, LTD.   |  LOLA TRAVEL COMPANY, INC.   |  GENERAL AMERICAN LIFE INSURANCE CO   |  METROPOLITAN TOWER LIFE INSURANCE CO   |  METROPOLITAN TOWER LIFE INSURANCE CO   |  METROPOLITAN LIFE INSURANCE CO   |  FREIGHTWAVES, INC.   |  UNLISTED SOFTWARE, INC.
JOHN 
 
O-MEARA 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  MIVI NEUROSCIENCE, INC.   |  LHCP PALM HOLDINGS LLC   |  LHCP MOTIVE, LLC
PAUL 
G. 
OXHOLM 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  CIS BALANCED INVESTMENT PARTNERS   |  CIS BALANCED INVESTMENT PARTNERS II   |  CIS MICROCAP GROWTH PARTNERS   |  CIS INDEX OVERWRITE PARTNERS   |  CIS INCOME + GROWTH PARTNERS   |  CIS AGGRESSIVE GROWTH PARTNERS   |  CIS HEDGED GROWTH PARTNERS
ROLF 
D. 
SCHMIDT 
DIRECTOR
INNOCOLL HOLDINGS, INC.
STEVEN 
A. 
SHALLCROSS 
EXECUTIVE OFFICER
INNOCOLL HOLDINGS, INC.   |  SYNTHETIC BIOLOGICS, INC.   |  THERIVA BIOLOGICS, INC.
ANTHONY 
 
WILD 
DIRECTOR
INNOCOLL HOLDINGS, INC.   |  SLATE PHARMACEUTICALS, INC.   |  SPROUT PHARMACEUTICALS, INC.   |  SERMONIX PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-02-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-01-22 
2012-12-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-01 
2012-07-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-06-26 
2012-03-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-01-24 
2011-08-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-06-28 
2011-04-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-03-22 
2010-12-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-08-13 
2010-07-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-05-13 
2010-03-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-12-21 
2009-07-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-04-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#